Long-term follow-up of pepsinogen I/II ratio after eradication of Helicobacter pylori in patients who underwent endoscopic mucosal resection for gastric cancer

被引:11
作者
Nam, Su Youn [1 ]
Jeon, Seong Woo [1 ]
Lee, Hyun Seok [1 ]
Kwon, Yong Hwan [1 ]
Park, Haeyoon [1 ]
Choi, Jin Woo [1 ]
机构
[1] Kyungpook Natl Univ, Sch Med, Med Ctr, Daegu, South Korea
关键词
Eradication; Helicobacter pylori; Long term follow-up; Pepsinogen; ACID-SUPPRESSIVE THERAPY; SERUM PEPSINOGEN; CELLULAR-LOCALIZATION; INFECTION; DIAGNOSIS; ATROPHY; RISK; IMMUNOFLUORESCENCE; CARCINOMA; HISTOLOGY;
D O I
10.1016/j.dld.2016.12.016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Although the pepsinogen I/II (PGI/II) ratio after Helicobacter pylori eradication is recovered at short-term follow-up, long-term follow-up studies of PGI/II are rare. Methods: A total of 773 patients with gastric cancer who underwent endoscopic resection and pepsinogen and H. pylori tests were enrolled. H. pylori was eradicated in these patients. Endoscopic and pepsinogen tests were performed every year. A low PGI/II ratio was defined as <= 3. Results: The PGI/II ratio was higher in non-infected patients (n = 275, 4.99) than infected patients (n = 498, 3.53). After H. pylori eradication, the PGI/II ratio increased to 5.81 and 5.63 after 1 and 2 years (each p < 0.05). The PGI/II ratio in the non-eradication group decreased to 3.94 and 2.75 after 1 and 2 years. The PGI/II ratio in the H. pylori eradication group became similar to that of the H. pylori-negative group at 3 (4.48 vs. 4.34), 4 (4.88 vs. 4.34), and 5 years (4.89 vs. 4.23). The adjusted odds ratios for a lower PG I/II ratio in the non-eradication group compared to the eradication group were 4.78 (95% CI 2.15-10.67) after 1 year and 8.13 (95% CI 2.56-25.83) after 2 years. Conclusions: After H. pylori eradication, the PGI/II ratio increased and was similar to that of H. pylori-negative controls for up to 5 years of follow-up. (C) 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:500 / 506
页数:7
相关论文
共 33 条
  • [1] Endoscopic Gastric Cancer Screening and Surveillance in High-Risk Groups
    Choi, Il Ju
    [J]. CLINICAL ENDOSCOPY, 2014, 47 (06) : 497 - 503
  • [2] Natural history of Helicobacter pylori infection
    Correa, P.
    Piazuelo, M. B.
    [J]. DIGESTIVE AND LIVER DISEASE, 2008, 40 (07) : 490 - 496
  • [3] Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma
    Dinis-Ribeiro, M
    da Costa-Pereira, A
    Lopes, C
    Barbosa, J
    Guilherme, M
    Moreira-Dias, L
    Lomba-Viana, H
    Silva, R
    Abreu, N
    Lomba-Viana, R
    [J]. NEOPLASIA, 2004, 6 (05): : 449 - 456
  • [4] Do Mi Young, 2009, Korean J Gastroenterol, V53, P76
  • [5] Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
    Ferlay, Jacques
    Soerjomataram, Isabelle
    Dikshit, Rajesh
    Eser, Sultan
    Mathers, Colin
    Rebelo, Marise
    Parkin, Donald Maxwell
    Forman, David
    Bray, Freddie
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) : E359 - E386
  • [6] Furuta T, 1997, AM J GASTROENTEROL, V92, P84
  • [7] Noninvasive versus histologic detection of gastric atrophy in a hispanic population in North America
    Graham, DY
    Nurgalieva, ZZ
    El-Zimaity, HMT
    Opekun, AR
    Campos, A
    Guerrero, L
    Chavez, A
    Cardenas, V
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (03) : 306 - 314
  • [8] Serum pepsinogen II: A neglected but useful biomarker to differentiate between diseased and normal stomachs
    He, Cai-yun
    Sun, Li-ping
    Gong, Yue-hua
    Xu, Qian
    Dong, Nan-nan
    Yuan, Yuan
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (06) : 1039 - 1046
  • [9] Alteration of correlation between serum pepsinogen concentrations and gastric acid secretion after H. pylori eradication
    Iijima, Katsunori
    Koike, Tomoyuki
    Abe, Yasuhiko
    Ara, Nobuyuki
    Uno, Kaname
    Imatani, Akira
    Ohara, Shuichi
    Shimosegawa, Tooru
    [J]. JOURNAL OF GASTROENTEROLOGY, 2009, 44 (08) : 819 - 825
  • [10] Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach
    Iijima, Katsunori
    Abe, Yasuhiko
    Kikuchi, Ryosuke
    Koike, Tomoyuki
    Ohara, Shuichi
    Sipponen, Pentti
    Shimosegawa, Tooru
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (07) : 853 - 859